lisähappina

Lisähappina is a Finnish term that translates to "supplementary oxygen" or "additional oxygen." It refers to the medical administration of oxygen gas at a concentration higher than that found in ambient air, typically to individuals experiencing hypoxemia or other respiratory distress. The primary goal of supplementary oxygen therapy is to increase the amount of oxygen delivered to the body's tissues, thereby improving oxygenation and alleviating symptoms associated with insufficient oxygen levels.

This therapy is prescribed and administered by healthcare professionals and can be delivered through various methods, including nasal cannulas, face masks, or in more critical situations, through mechanical ventilation. The decision to use lisähappina is based on factors such as the patient's blood oxygen saturation levels, clinical presentation, and underlying medical condition. Common conditions that may necessitate supplementary oxygen include pneumonia, chronic obstructive pulmonary disease (COPD), heart failure, and sleep apnea.

The administration of lisähappina is carefully monitored to ensure appropriate oxygen levels are maintained without causing adverse effects, such as oxygen toxicity or the suppression of the respiratory drive in certain patients. The specific flow rate and duration of oxygen therapy are tailored to the individual needs of each patient to optimize therapeutic benefit and patient safety.